These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 29533874)

  • 21. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies.
    Di Pietro O; Pérez-Areales FJ; Juárez-Jiménez J; Espargaró A; Clos MV; Pérez B; Lavilla R; Sabaté R; Luque FJ; Muñoz-Torrero D
    Eur J Med Chem; 2014 Sep; 84():107-17. PubMed ID: 25016233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring Structure-Activity Relationship in Tacrine-Squaramide Derivatives as Potent Cholinesterase Inhibitors.
    Svobodova B; Mezeiova E; Hepnarova V; Hrabinova M; Muckova L; Kobrlova T; Jun D; Soukup O; Jimeno ML; Marco-Contelles J; Korabecny J
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31430943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel class of multitarget anti-Alzheimer benzohomoadamantane‒chlorotacrine hybrids modulating cholinesterases and glutamate NMDA receptors.
    Pérez-Areales FJ; Turcu AL; Barniol-Xicota M; Pont C; Pivetta D; Espargaró A; Bartolini M; De Simone A; Andrisano V; Pérez B; Sabate R; Sureda FX; Vázquez S; Muñoz-Torrero D
    Eur J Med Chem; 2019 Oct; 180():613-626. PubMed ID: 31351393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
    Chioua M; Buzzi E; Moraleda I; Iriepa I; Maj M; Wnorowski A; Giovannini C; Tramarin A; Portali F; Ismaili L; López-Alvarado P; Bolognesi ML; Jóźwiak K; Menéndez JC; Marco-Contelles J; Bartolini M
    Eur J Med Chem; 2018 Jul; 155():839-846. PubMed ID: 29958119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
    Chen Y; Zhu J; Mo J; Yang H; Jiang X; Lin H; Gu K; Pei Y; Wu L; Tan R; Hou J; Chen J; Lv Y; Bian Y; Sun H
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):290-302. PubMed ID: 29278947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
    Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
    J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease.
    Chen Y; Sun J; Peng S; Liao H; Zhang Y; Lehmann J
    Arch Pharm (Weinheim); 2013 Dec; 346(12):865-71. PubMed ID: 24203864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tacrine-propargylamine derivatives with improved acetylcholinesterase inhibitory activity and lower hepatotoxicity as a potential lead compound for the treatment of Alzheimer's disease.
    Mao F; Li J; Wei H; Huang L; Li X
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):995-1001. PubMed ID: 25792506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total Synthesis of Pulmonarin B and Design of Brominated Phenylacetic Acid/Tacrine Hybrids: Marine Pharmacophore Inspired Discovery of New ChE and Aβ Aggregation Inhibitors.
    Cheng ZQ; Song JL; Zhu K; Zhang J; Jiang CS; Zhang H
    Mar Drugs; 2018 Aug; 16(9):. PubMed ID: 30134630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of multifunctional ligands targeting acetylcholinesterase and alpha 7 nicotinic acetylcholine receptor.
    Cieslikiewicz-Bouet M; Naldi M; Bartolini M; Pérez B; Servent D; Jean L; Aráoz R; Renard PY
    Biochem Pharmacol; 2020 Jul; 177():114010. PubMed ID: 32360492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease.
    Jeřábek J; Uliassi E; Guidotti L; Korábečný J; Soukup O; Sepsova V; Hrabinova M; Kuča K; Bartolini M; Peña-Altamira LE; Petralla S; Monti B; Roberti M; Bolognesi ML
    Eur J Med Chem; 2017 Feb; 127():250-262. PubMed ID: 28064079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrine-xanomeline and tacrine-iperoxo hybrid ligands: Synthesis and biological evaluation at acetylcholinesterase and M
    Maspero M; Volpato D; Cirillo D; Yuan Chen N; Messerer R; Sotriffer C; De Amici M; Holzgrabe U; Dallanoce C
    Bioorg Chem; 2020 Mar; 96():103633. PubMed ID: 32032848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors.
    de Aquino RA; Modolo LV; Alves RB; de Fátima Â
    Org Biomol Chem; 2013 Dec; 11(48):8395-409. PubMed ID: 24186541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
    Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
    Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease.
    Keri RS; Quintanova C; Marques SM; Esteves AR; Cardoso SM; Santos MA
    Bioorg Med Chem; 2013 Aug; 21(15):4559-69. PubMed ID: 23768661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Thiratmatrakul S; Yenjai C; Waiwut P; Vajragupta O; Reubroycharoen P; Tohda M; Boonyarat C
    Eur J Med Chem; 2014 Mar; 75():21-30. PubMed ID: 24508831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment--synthesis, biological evaluation and molecular modeling studies.
    Spilovska K; Korabecny J; Kral J; Horova A; Musilek K; Soukup O; Drtinova L; Gazova Z; Siposova K; Kuca K
    Molecules; 2013 Feb; 18(2):2397-418. PubMed ID: 23429378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R ; Morral J; Muñoz-Torrero D; Badia A; Baños JE; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 2000 Nov; 43(24):4657-66. PubMed ID: 11101357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.